Lista de obras -

207-nm UV light - a promising tool for safe low-cost reduction of surgical site infections. I: in vitro studies

artículo científico publicado en 2013

A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens

artículo científico publicado en 2011

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease

artículo científico publicado en 2003

A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

artículo científico publicado en 2003

A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen

artículo científico publicado en 2010

Acceptability of male circumcision for the prevention of HIV among high-risk heterosexual men in Thailand

artículo científico publicado en 2010

Advances in Antiretroviral Therapy

Advances in antiretroviral therapy

scientific article published on 01 April 2007

Advances in antiretroviral therapy

artículo científico publicado en 2005

Advances in antiretroviral therapy

artículo científico publicado en 2006

Advances in antiretroviral therapy

artículo científico publicado en 2009

Advances in antiretroviral therapy

artículo científico publicado en 2010

Advances in antiretroviral therapy

artículo científico publicado en 2012

Advances in antiretroviral therapy

artículo científico publicado en 2011

Advances in antiretroviral therapy.

artículo científico publicado en 2003

Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.

artículo científico publicado en 2004

Alpha Interferon and Acyclovir Treatment of Herpes Simplex Virus in Lymphoid Cell Cultures

artículo científico publicado en 1982

Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118).

artículo científico publicado en 2006

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

scientific article published on 01 November 2019

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel

scientific article published on July 2008

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

scientific article published on August 2008

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

artículo científico publicado en 2003

Antiretroviral treatment as prevention.

artículo científico publicado en 2011

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

artículo científico publicado en 2002

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

artículo científico publicado en 2008

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

artículo científico publicado en 2010

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

artículo científico publicado en 2012

Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State Area

artículo científico publicado en 2020

Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience

artículo científico publicado en 2008

Baby steps on the road to HIV eradication.

artículo científico publicado en 2013

Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence

artículo científico publicado en 2016

C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s

artículo científico publicado en 2004

CROI 2013: Advances in antiretroviral therapy.

artículo científico

Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy

artículo científico publicado en 2006

Clinical practice. Management of newly diagnosed HIV infection

artículo científico publicado en 2005

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections

artículo científico publicado en 2004

Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries

artículo científico publicado en 2009

Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure

artículo científico publicado en 2014

Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals

artículo científico publicado en 2004

Cornell/amfAR Symposium. Strategies of antiretroviral therapy.

artículo científico publicado en 2002

Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission

artículo científico publicado en 2006

Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine

artículo científico publicado en 2004

Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.

artículo científico publicado en 2002

Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data

artículo científico publicado en 2008

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial

artículo científico publicado en 2002

Ebola and quarantine

artículo científico publicado en 2014

Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir

artículo científico publicado en 2002

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

artículo científico publicado en 2015

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

artículo científico publicado en 2013

Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial

artículo científico publicado en 2019

HIV Drug Resistance: Implications for Management.

artículo científico publicado en 2002

HIV vaccine research: the way forward

artículo científico publicado en 2008

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

artículo científico publicado en 2015

HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.

artículo científico publicado en 2004

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients

artículo científico publicado en 2002

Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

artículo científico publicado en 2017

Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.

artículo científico publicado en 2008

Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment

artículo científico publicado en 2013

Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand

artículo científico publicado en 2009

Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine

artículo científico publicado en 2004

In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities

scientific article published on 25 June 2013

Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy

artículo científico publicado en 2016

Increasing choices for HIV therapy

artículo científico publicado en 2002

Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects

artículo científico publicado en 2003

Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants

artículo científico publicado en 2013

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

artículo científico publicado en 2004

Lessons Drawn From Recent HIV Vaccine Efficacy Trials ⬇️

artículo científico publicado el 1 de diciembre de 2010

Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women

artículo científico publicado en 2009

Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients

artículo científico publicado en 2010

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

artículo científico publicado en 2018

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

artículo científico publicado en 2012

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis

artículo científico publicado en 2005

Nucleoside analogue reverse transcriptase inhibitor options: a re-examination of the class

artículo científico publicado en 2006

Patents versus patients? Antiretroviral therapy in India

artículo científico publicado en 2005

Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherence

artículo científico publicado en 2014

Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy

artículo científico publicado en 2009

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants

artículo científico publicado en 2014

Poor agreement between 2 assays for measuring low levels of HIV-1 viral load.

artículo científico publicado en 2009

Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.

artículo científico publicado en 2003

Potent Inhibition of Human Immunodeficiency Virus Type 1 in Primary T Cells and Alveolar Macrophages by a Combination Anti-Rev Strategy Delivered in an Adeno-Associated Virus Vector

Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans

artículo científico publicado en 2011

Prognostic value of baseline human immunodeficiency virus type 1 DNA measurement for disease progression in patients receiving nucleoside therapy

artículo científico publicado en 2002

Questions to and answers from the International AIDS Society-USA Resistance Testing Guidelines Panel

artículo científico publicado en 2003

Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults

artículo científico publicado en 2010

Scott Hammer--integrating research with politics, public policy, and international collaborations. Interviewed by Marilynn Larkin

artículo científico publicado en 2003

Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120.

artículo científico publicado en 2017

Single-dose nevirapine and drug resistance: the more you look, the more you find

artículo científico publicado en 2005

Specificity and 6-month durability of immune responses induced by DNA and recombinant modified vaccinia Ankara vaccines expressing HIV-1 virus-like particles

artículo científico publicado en 2014

Statistical interpretation of the RV144 HIV vaccine efficacy trial in Thailand: a case study for statistical issues in efficacy trials

artículo científico publicado en 2011

Testing the waters: Ethical considerations for including PrEP in a phase IIb HIV vaccine efficacy trial

artículo científico publicado en 2015

The Global HIV Drug Resistance Surveillance Program: a partnership between WHO and IAS. International AIDS Society

artículo científico publicado en 2002

The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studies

artículo científico publicado en 2020

The challenge of HIV-1 subtype diversity

artículo científico publicado en 2008

The challenge of HIV-1 subtype diversity.

artículo científico publicado en 2008

The relationship between genotypic sensitivity score and treatment outcomes in late stage HIV disease after supervised HAART.

artículo científico publicado en 2009

Translational research insights from completed HIV vaccine efficacy trials

artículo científico publicado en 2013

Transmitted drug resistance among antiretroviral-naive patients with established HIV type 1 infection in Santo Domingo, Dominican Republic and review of the Latin American and Caribbean literature

artículo científico publicado en 2011

Treatment for adult HIV infection: 2004 recommendations of the International AIDS Society-USA Panel.

artículo científico publicado en 2004

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society--USA panel

artículo científico publicado en 2006

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel

artículo científico publicado en 2006

Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083

artículo científico publicado en 2015

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials

artículo científico publicado en 2003

Which New Health Technologies Do We Need to Achieve an End to HIV/AIDS?

artículo científico publicado en 2016

Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptase

artículo científico publicado en 2012

Lista de obras de

207-nm UV light - a promising tool for safe low-cost reduction of surgical site infections. I: in vitro studies

A Sequential Phase 2b Trial Design for Evaluating Vaccine Efficacy and Immune Correlates for Multiple HIV Vaccine Regimens

A randomized trial of 2 different 4-drug antiretroviral regimens versus a 3-drug regimen, in advanced human immunodeficiency virus disease

A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir.

A randomized, placebo-controlled trial of abacavir intensification in HIV-1-infected adults with virologic suppression on a protease inhibitor-containing regimen

Acceptability of male circumcision for the prevention of HIV among high-risk heterosexual men in Thailand

Advances in Antiretroviral Therapy

Advances in antiretroviral therapy

Advances in antiretroviral therapy

Advances in antiretroviral therapy

Advances in antiretroviral therapy

Advances in antiretroviral therapy

Advances in antiretroviral therapy

Advances in antiretroviral therapy

Advances in antiretroviral therapy.

Advances in antiretroviral therapy. Highlights of the 11th Conference on Retroviruses and Opportunistic Infections, February 8-11, 2004, San Francisco, California, USA.

Alpha Interferon and Acyclovir Treatment of Herpes Simplex Virus in Lymphoid Cell Cultures

Amdoxovir versus placebo with enfuvirtide plus optimized background therapy for HIV-1-infected subjects failing current therapy (AACTG A5118).

Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel

Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

Antiretroviral treatment as prevention.

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel

Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

Assessing Knowledge of HIV Vaccines and Biomedical Prevention Methods Among Transgender Women in the New York City Tri-State Area

Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience

Baby steps on the road to HIV eradication.

Brief Report: Preventing HIV-1 Infection in Women Using Oral Preexposure Prophylaxis: A Meta-analysis of Current Evidence

C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s

CROI 2013: Advances in antiretroviral therapy.

Changes in hepatitis C virus (HCV) viral load and interferon-alpha levels in HIV/HCV-coinfected patients treated with highly active antiretroviral therapy

Clinical practice. Management of newly diagnosed HIV infection

Combination therapy with polymyxin B for the treatment of multidrug-resistant Gram-negative respiratory tract infections

Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries

Comparing interferon-gamma release assays to tuberculin skin test in Thai children with tuberculosis exposure

Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals

Cornell/amfAR Symposium. Strategies of antiretroviral therapy.

Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission

Detection of drug-resistant minority variants of HIV-1 during virologic failure of indinavir, lamivudine, and zidovudine

Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter.

Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data

Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial

Ebola and quarantine

Effect of coadministration of nelfinavir, indinavir, and saquinavir on the pharmacokinetics of amprenavir

Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized Trials

Efficacy trial of a DNA/rAd5 HIV-1 preventive vaccine

Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial

HIV Drug Resistance: Implications for Management.

HIV vaccine research: the way forward

HIV-1 VACCINES. Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies

HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.

HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients

Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy Trial

Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Advances in antiretroviral therapy.

Immune Activation While on Potent Antiretroviral Therapy Can Predict Subsequent CD4+ T-Cell Increases Through 15 Years of Treatment

Immunologic markers as predictors of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV and tuberculosis coinfected persons in Thailand

Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine

In pursuit of an HIV vaccine: designing efficacy trials in the context of partially effective nonvaccine prevention modalities

Incidence of Diabetes Mellitus and Obesity and the Overlap of Comorbidities in HIV+ Hispanics Initiating Antiretroviral Therapy

Increasing choices for HIV therapy

Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects

Intentions to use preexposure prophylaxis among current phase 2B preventive HIV-1 vaccine efficacy trial participants

Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy

Lessons Drawn From Recent HIV Vaccine Efficacy Trials ⬇️

Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women

Low frequency nonnucleoside reverse-transcriptase inhibitor-resistant variants contribute to failure of efavirenz-containing regimens in treatment- experienced patients

Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial

Multiple antibody specificities (gp41, V1V2, and V3) elicited in the phase II multiclade (A, B, C) HIV-1 DNA prime, rAd5 boost vaccine trial

Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis

Nucleoside analogue reverse transcriptase inhibitor options: a re-examination of the class

Patents versus patients? Antiretroviral therapy in India

Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherence

Persistent minority K103N mutations among women exposed to single-dose nevirapine and virologic response to nonnucleoside reverse-transcriptase inhibitor-based therapy

Phase I/II randomized trial of safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC-HIV (vCP1452) prime/LIPO-5 boost in healthy, HIV-1-uninfected adult participants

Poor agreement between 2 assays for measuring low levels of HIV-1 viral load.

Population pharmacokinetics and pharmacodynamics of efavirenz, nelfinavir, and indinavir: Adult AIDS Clinical Trial Group Study 398.